Vineet Datta, Senior Director of Global Strategy at Datar Cancer Genetics Limited, shared a post on LinkedIn:
“It was a pleasure to meet Professor Kefah Mokbel and discuss the growing importance of personalised genomics in breast cancer.
Our great conversation reinforced the importance of innovation and collaboration in advancing treatment selection, AI driven data analytics and more individualised patient care.
As science continues to evolve, the opportunity lies in translating these insights into practical, accessible, and impactful clinical pathways for patients.
A thoughtful and timely exchange on the future of breast cancer care.
Thank you for your gracious hospitality.”
Other articles featuring Vineet Datta on OncoDaily.